Businesses Fearing a Recession Should Use AI to Optimize Their Supply Chain

 

Thanks to high inflation, rising interest rates, and massive job cuts, fear of recession has become modus operandi for most businesses. Even with year-over-year inflation somewhat cooling and with the shuttering of Silicon Valley Bank, the Federal Reserve shows no signs of continuing its path of demand destruction with interest rate hikes. A bearish economic climate drives layoffs, and as they enter into the thousands, especially in the tech industry, more and more companies are grappling with significant gaps in their workflow. Some in the enterprise automation space see this as a critical moment for companies to insulate themselves against a rickety economy, calling for businesses to use AI to optimize their supply chain.

Today, AI is playing in role in every layer of business, and is providing enterprise automation solutions to help cover some of the pressure points for businesses. Companies facing labor and skill shortage are using AI to automate tasks, for inventory management and consumer behavior predictions, and even to improve delivery times, inventory and warehouse management. All these points of automation, especially ones that create logistics efficiencies for a company’s supply chain, are critical and have compounding effects across a company’s finances and operations.

Bob Rogers, co-author of Demystifying AI for the Enterprise: A Playbook for Business Value and Digital Transformation and CEO of Oii.ai, which helps businesses find the right supply chain set-up through its AI-enabled software, explains why companies should deploy AI to optimize their supply chain.

Bob’s Thoughts:

“My company Oii.ai is using AI in two key areas. First, we monitor data from supply chains and we use AI to identify what that data means and how it connects to our supply chain modeling software. The other place we use AI is to predict what kinds of disruptions supply chains might need to be prepared for, so that we can build the most robust supply chain possible.

In an environment where inflation is putting pressure on companies to maintain margins without raising prices too much, a key opportunity is to reduce the cost of your supply chain by reducing inefficiencies and inventory. Software such as Oii.ai can optimize the supply chain to reduce costs and support margins without raising prices.”

Article written by Aarushi Maheshwari.

Follow us on social media for the latest updates in B2B!

Image

Latest

AMAG Technology
AMAG Technology: Control, Reliability, and Customer-First Supply Chain Excellence
April 2, 2025

At AMAG Technology, being customer-obsessed goes beyond a mindset—it’s built into every part of the operation. One of the company’s greatest strengths lies in its ability to manufacture its own products, offering a level of supply chain control that few competitors can match. Allan Price, Head of Global Supply Chain at AMAG, emphasizes how this…

Read More
visitor management solution
Reinventing Visitor Management Solution with Symmetry GUEST
April 2, 2025

In an age where speed and security are paramount, the traditional paper logbook is becoming a relic of the past. AMAG Technology’s Symmetry Guest system offers a modern, digital solution that redefines the way organizations welcome and manage visitors. Gone are the days of long lines and confusion at the front desk—Symmetry Guest empowers hosts…

Read More
AMAG
Driven by Customers, Defined by Innovation: Inside AMAG’s Customer-Obsessed Approach
April 2, 2025

AMAG Technology continues to strengthen its customer-obsessed culture by actively listening to both internal and external voices. As shared by Kyle Gordon, Executive Vice President of Global Sales, Marketing, & Commercial Excellence, the company is focused on improving processes, responding with speed, and driving innovation—while honoring its legacy and delivering unique value within the industry.

Read More
biotech
Biotech Moves Smarter: IDDI Powers Data-Driven Drug Innovation
April 2, 2025

As biotech innovation accelerates, small and mid-size pharmaceutical companies are becoming key players in bringing new treatments to market. Yet many of these organizations face steep challenges when navigating clinical trial design, regulatory approval, and data integrity. According to a McKinsey Global Institute report, industries like biotech could help generate up to $50 trillion…

Read More